Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Net Margin (2024 - 2025)

Allarity Therapeutics' Net Margin history spans 2 years, with the latest figure at 5716.95% for Q4 2025.

  • For Q4 2025, Net Margin fell 422038.0% year-over-year to 5716.95%; the TTM value through Dec 2025 reached 6070.81%, up 221874.0%, while the annual FY2025 figure was 3509.69%, N/A changed from the prior year.
  • Net Margin reached 5716.95% in Q4 2025 per ALLR's latest filing, up from 4922.81% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 24304.0% in Q3 2024 to a low of 391.78% in Q2 2024.